These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19506386)

  • 21. Dietary modulators of peroxisome proliferator-activated receptors: implications for the prevention and treatment of metabolic syndrome.
    Guri AJ; Hontecillas R; Bassaganya-Riera J
    J Nutrigenet Nutrigenomics; 2008; 1(3):126-35. PubMed ID: 19776622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corticosteroid therapy in asthma: predictors of responsiveness.
    Mjaanes CM; Whelan GJ; Szefler SJ
    Clin Chest Med; 2006 Mar; 27(1):119-32, vii. PubMed ID: 16543057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment.
    Song QQ; Xie WY; Tang YJ; Zhang J; Liu J
    Pharmacogenomics; 2017 Feb; 18(3):293-316. PubMed ID: 28112586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of resistin as a regulator of inflammation: Implications for various human pathologies.
    Filková M; Haluzík M; Gay S; Senolt L
    Clin Immunol; 2009 Nov; 133(2):157-70. PubMed ID: 19740705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice.
    Sohet FM; Neyrinck AM; Pachikian BD; de Backer FC; Bindels LB; Niklowitz P; Menke T; Cani PD; Delzenne NM
    Biochem Pharmacol; 2009 Dec; 78(11):1391-400. PubMed ID: 19632207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of high-fat-diet-induced metabolic syndrome by a compound from Balanophora polyandra Griff in mice.
    Tao R; Ye F; He Y; Tian J; Liu G; Ji T; Su Y
    Eur J Pharmacol; 2009 Aug; 616(1-3):328-33. PubMed ID: 19540228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation: the dynamic force of health and disease.
    Vassileva V; Piquette-Miller M
    Clin Pharmacol Ther; 2014 Oct; 96(4):401-5. PubMed ID: 25236660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Glance at the Use of Glucocorticoids in Rare Inflammatory and Autoimmune Diseases: Still an Indispensable Pharmacological Tool?
    Ronchetti S; Ayroldi E; Ricci E; Gentili M; Migliorati G; Riccardi C
    Front Immunol; 2020; 11():613435. PubMed ID: 33584696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M; Fujita T
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between glucocorticoid receptors and glucocorticoid resistance in children with idiopathic thrombocytopenia purpura].
    Wang Y; Mai HR; Lin L; Yuan XL; Shi HS; Liu SX; Li CG
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Sep; 11(9):714-6. PubMed ID: 19755017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages.
    McColl A; Bournazos S; Franz S; Perretti M; Morgan BP; Haslett C; Dransfield I
    J Immunol; 2009 Aug; 183(3):2167-75. PubMed ID: 19597001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-21 as a new therapeutic target for immune-mediated diseases.
    Monteleone G; Pallone F; Macdonald TT
    Trends Pharmacol Sci; 2009 Aug; 30(8):441-7. PubMed ID: 19616319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glucocorticoid therapy in internal medicine. Pharmacodynamic therapy. II].
    Medau HJ
    Med Welt; 1973 Oct; 24(42):1589-93. PubMed ID: 4543574
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
    Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid receptor polymorphisms in major depression.
    Claes S
    Ann N Y Acad Sci; 2009 Oct; 1179():216-28. PubMed ID: 19906242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucocorticoids and the cardiovascular system: state of the art.
    Nussinovitch U; de Carvalho JF; Pereira RM; Shoenfeld Y
    Curr Pharm Des; 2010; 16(32):3574-85. PubMed ID: 20977421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective prostacyclin receptor agonism augments glucocorticoid-induced gene expression in human bronchial epithelial cells.
    Wilson SM; Shen P; Rider CF; Traves SL; Proud D; Newton R; Giembycz MA
    J Immunol; 2009 Nov; 183(10):6788-99. PubMed ID: 19880449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of obesity and related pathology: linking immune responses to metabolic stress.
    Karalis KP; Giannogonas P; Kodela E; Koutmani Y; Zoumakis M; Teli T
    FEBS J; 2009 Oct; 276(20):5747-54. PubMed ID: 19754872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance.
    Tabata M; Kadomatsu T; Fukuhara S; Miyata K; Ito Y; Endo M; Urano T; Zhu HJ; Tsukano H; Tazume H; Kaikita K; Miyashita K; Iwawaki T; Shimabukuro M; Sakaguchi K; Ito T; Nakagata N; Yamada T; Katagiri H; Kasuga M; Ando Y; Ogawa H; Mochizuki N; Itoh H; Suda T; Oike Y
    Cell Metab; 2009 Sep; 10(3):178-88. PubMed ID: 19723494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Choice of glucocorticoid dosage for suppression of autoimmunity in rheumatism].
    Levin AI; Smolenskiĭ GA; Konovalov IuN
    Ter Arkh; 1968 Dec; 40(12):19-23. PubMed ID: 5746535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.